Clinical research promotes development of nephrology in China: An analysis of 20 years of scientific publications

Renal Failure

Volumn 34, Issue 4, 2012, Pages 472-479

  Kou, Jia ^a   Zhang, Yan ^a   Zhang, Xue Guang ^a   Liang, Shuang ^a   Cai, Guang Yan ^a   Chen, Xiang Mei ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

China; Impact factors; Nephrology; Scientific publications

Indexed keywords

ARTICLE; CHINA; CLINICAL RESEARCH; CLINICAL TRIAL; HONG KONG; MEDLINE; NEPHROLOGY; PRIORITY JOURNAL; PUBLISHING; QUALITY CONTROL; SCIENTIFIC LITERATURE; TAIWAN; TREND STUDY; UROLOGY;

BIOMEDICAL RESEARCH; CHINA; HUMANS; JOURNAL IMPACT FACTOR; NEPHROLOGY; PERIODICALS AS TOPIC; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84859621546     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2011.653776     Document Type: Article

References (30)

1. Xie Y, Chen X. Epidemiology, major outcomes, risk factors, prevention and management of chronic kidney disease in China. Am J Nephrol. 2008;28:1-7. (Pubitemid 350126487)
2. Zhang W, Gong Z, Peng X, Tang S, Bi M, Huang W. Clinical characteristics and outcomes of rural patients with ESRD in Guangxi, China: One dialysis center experience. Int Urol Nephrol. 2010;42:195-204.
3. Dialysis and Transplantation Registration Group. The report about the registration of dialysis and transplantation in China. Chin J Nephrol. 1999;17:77-78.
4. Cai GY, Chen XM. Immunoglobulin A nephropathy in China: Progress and challenges. Am J Nephrol. 2009;30:268-273.
5. Wang H, Zhang L, Lv J. Prevention of the progression of chronic kidney disease: Practice in China. Kidney Int. 2005;94: S63-S67.
6. Lin SY. Nephrology in China: A great mission and momentous challenge. Kidney Int. 2003;63(Suppl. 83):S108-S110.
7. Han Q, Chen L, Evans TG, Summerskill W. Recent scientific health developments in China. Lancet 2010;375: 1055-1056.
8. Zhou P, Leydesdorff L. ISSI Newsletter No. 13. March 2008: 7-9.
9. Lawrence PA. The politics of publication. Nature 2003;422:259-261. (Pubitemid 36378340)
10. Wallin JA. Bibliometric methods: Pitfalls and possibilities. Basic Clin Pharmacol Toxicol. 2005;97:261-275. (Pubitemid 41608118)
11. ISI Journal Citation Reports, Institute for Scientific Information. 2006. Available at: http://isiknowledge.com. Accessed April 20, 2008.
12. http://www.nytimes.com/2010/08/16/business/global/16yuan. html. Accessed February 22, 2011.
13. Wells WA. The returning tide: How China, the world's most populous country, is building a competitive research base. J Cell Biol. 2007;176:376-401.
14. Goh KL, Farrell GC. Publications from China: The sleeping giant awakens. J Gastroenterol Hepatol. 2008;23:341-343. (Pubitemid 351342082)
15. Thomson Scientific. Scientific output in China is growing. 2007. Available at: http://scientific.thomson.com/press/2007/ 8423909. Accessed February 22, 2011.
16. http://www.telegraph.co.uk/news/worldnews/asia/china/ 7075698/China-to-lead-world-scientific-research-by-2020. html. Accessed February 21, 2011.
17. Liu J. Scientific publication in China: An overview and some thoughts on improvement. Sci Ed. 2004;27:120-121.
18. Despite Decline in Share of Global Output, US Science Impact Still Strong, Says Thomson Reuters. Available at: http:// science.thomsonreuters.com/ press/2009/8500846/. Accessed February 21, 2011.
19. Andersen J, Belmont J, Cho CT. Journal impact factor in the era of expanding literature. J Microbiol Immunol Infect. 2006;39:436-443. (Pubitemid 46374208)
20. Falagas ME, Kouranos VD, Arencibia-Jorge R, Karageorgopoulos DE. Comparison of SCImago journal rank indicator with journal impact factor. FASEB J. 2008;22: 2623-2628.
21. Strippoli GFM, Craig JC, Schena FP. The number, quality and coverage of randomized controlled trials in nephrology. J Am Soc Nephrol. 2004;15:411-419. (Pubitemid 38140782)
22. Zeeuw DD, De Graeff PA. Clinical trial in nephrology at hard end point? J Am Soc Nephrol. 2004;15:506-508. (Pubitemid 38140795)
23. Cheng TO. Cardiology in contemporary China: An update. Int J Cardiol. 2008;126:147-159. (Pubitemid 351602109)
24. Mervis J. China's unique environment favors large intervention trials. Science 1995;270:1149-1151.
25. Wang J. Evidence-based medicine in China. Lancet 2010;375:532-533.
26. The Chinese Clinical Trial Register. Available at: http://www.chictr.org. Accessed December 14, 2009.
27. Liu X, Li Y, Yin S, Song S. Result publication of Chinese trials in World Health Organization primary registries. PLoS One. 2010;5:e12676.
28. Chen N, Wang W, Huang Y, et al. Community-based study on CKD subjects and the associated risk factors. Nephrol Dial Transplant. 2009;24:2117-2123.
29. Chen W, Chen W, Wang H, et al. Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China. Nephrol Dial Transplant. 2009;24: 1205-1212.
30. Shan Y, Zhang Q, Liu Z, Hu X, Liu D. Prevalence and risk factors associated with chronic kidney disease in adults over 40 years: A population study from Central China. Nephrology (Carlton). 2010;15:354-361.